Leading-edge Scientists in Innate Immunity Join Qu Biologics’ Scientific Advisory Board
15. Mai 2018 13:34 ET
|
Qu Biologics
VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies...